Donato is a senior executive with more than 25 years of international pharmaceutical industry experience. In his previous position as CFO of Hansa Biopharma, a Nasdaq Stockholm-listed biopharmaceutical company, he supported the progress of Hansa Biopharma’s R&D pipeline and its transformation to a commercial-stage company by contributing to the corporate business and financial strategy and securing growth financing in excess of USD 200 million. Prior to joining Hansa Biopharma, Donato was CFO at Basilea Pharmaceutica AG, a Swiss-listed biopharmaceutical company. Donato held other senior financial leadership positions, including Global Head of Finance & Services and Head of Global Controlling at Basilea. Donato holds a degree in Information Technology and an M.Sc. in Business Administration from the HfWU University Nürtingen-Geislingen, Germany.